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Tumor virusRhesus rhadinovirus (RRV), a primate γ-herpesvirus related to human Kaposi's sarcoma-associated
herpesvirus (KSHV), causes a similar pattern of pathogenesis. Previously, RRV was shown to express 7
pre-microRNAs (pre-miRNAs) in latently infected cells. Using deep sequencing, we analyzed the pattern of
small RNA expression in vivo using latently RRV-infected B-cell lymphoma and retroperitoneal ﬁbromatosis
tissues. We identiﬁed 15 virally encoded pre-miRNAs in both tumors, including all previously reported RRV
pre-miRNAs. Although all 15 RRV pre-miRNAs, like all 12 KSHV pre-miRNAs, are located 3′ to the conserved
viral ORF71 gene and in the same transcriptional orientation, only one RRV miRNA is homologous to a KSHV
miRNA. One previously identiﬁed RRV miRNA, miR-rR1-3, is actually a miRNA offset RNA (moRNA) derived
from sequences located adjacent to pre-miR-rR1-3. Several other RRV-derived moRNAs were obtained,
including one recovered N600 times. Together, this research provides a comprehensive list of the miRNAs
and moRNAs encoded by RRV..
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
MicroRNAs (miRNAs) are a family of ~22-nt noncoding RNAs
capable of posttranscriptionally downregulating the expression of
target mRNAs (Bartel, 2004). They are typically transcribed as one
arm of an ~80-nt RNA stem-loop foundwithin a noncoding region of a
capped and polyadenylated transcript referred to as a primary miRNA
(pri-miRNA) (Cai et al., 2004; Lee et al., 2002, 2004; Zeng and Cullen,
2003). These stem-loops are bound by the RNase III enzyme Drosha
and cleaved ~22 bp away from the loop to generate an ~60-nt RNA
hairpin, bearing an ~2-nt 3′ overhang, referred to as the precursor
miRNA (pre-miRNA) (Lee et al., 2003). The pre-miRNA is bound by
Exportin5 (Yi et al., 2003) and exported to the cytoplasm where the
pre-miRNA is recognized by Dicer, a second RNase III enzyme. Dicer
cleaves ~22 bp from the base of the pre-miRNA to release the terminal
loop and generate a second ~2-nt 3′ overhang (Hutvagner et al., 2001;
Lee et al., 2002). One strand of the resultant miRNA duplex
intermediate is then loaded into the RNA-induced silencing complex
(RISC) (Hammond et al., 2000), while the remaining strand, referred
to as the star or passenger strand, is degraded (Matranga et al., 2005).
However, this discrimination, which is largely regulated by the
stability of base pairing at the 5′ ends of the duplex, is rarely absolute.
MiRNAs function as guides to direct RISC to mRNA transcripts bearingcomplementary target sequences, typically in the 3′UTR, leading to
inhibition of protein expression (Martinez et al., 2002; Schwarz et al.,
2002).While functional miRNA target sites onmammalianmRNAs are
generally only partially complementary, full mRNA sequence com-
plementarity to nucleotides 2 through 8 of the miRNA, referred to as
the seed sequence, is commonly observed (Bartel, 2004).
MiRNA offset RNAs (moRNAs) are a recently discovered class of
small RNAs closely related to miRNAs (Shi et al., 2009). MoRNAs
derive from sequences located immediately adjacent to the mature
miRNA and miRNA star strands in the pri-miRNA precursor and have
been recovered at low levels in several small RNA deep sequencing
efforts (Babiarz et al., 2008; Jurak et al., 2010; Ruby et al., 2007; Shi
et al., 2009; Umbach and Cullen, 2010). Although they appear to form
“moRNA duplex intermediates”with their corresponding star strands,
complete with short 3′ overhangs, the process by which they are
generated remains unclear, and whether or not they are loaded into
RISC and have functional activity is currently unknown. However,
moRNA processing is clearly linked to the excision of the ﬂanking
miRNA duplex.
In addition to a relatively low level of moRNAs, several herpes-
viruses, of both human and nonhuman origin, have been found to
express high levels of miRNAs, including the oncogenic human
rhadinovirus Kaposi's sarcoma-associated herpesvirus (KSHV). Se-
quencing analysis of small RNAs expressed in latently KSHV-infected
human B cells has revealed that KSHV encodes 12 pre-miRNAs that are
all located within a single cluster contained within the latency-
associated region of the KSHV genome, 3′ of the ORF71 gene (Cai
Table 1
Viral miRNAs and moRNAs recovered from RRV-induced retroperitoneal ﬁbromatosis
tissue and B-cell lymphomas.
Retroperitoneal ﬁbromatosis
(18483)
B-cell lymphoma (19286)
miRNA moRNA miRNA moRNA
5p 3p 5p 3p 5p 3p 5p 3p
miR-rR1-1 1456 1 1984 1 1
miR-rR1-2 1582 1159
miR-rR1-3 1921 4400 12 807 1930 19 2
miR-rR1-4 37 1363* 20 479*
miR-rR1-5 11124 531 4492 223
miR-rR1-6 9727 61 177 7633 56 434
miR-rR1-7 1600 555 590 274
miR-rR1-8 7 770 20 1029
miR-rR1-9 288 14 4 501 20 12
miR-rR1-10 111 1 102 6
miR-rR1-11 291 212 195 329
miR-rR1-12 330 19 298 17
miR-rR1-13 9 191,963 11 95,377
miR-rR1-14 75 1 40 2
miR-rR1-15 58 13,273 23 7938
The recovery frequency of each miRNA or moRNA is shown, with bolded values
indicating small RNAs that have not been previously reported. Both miRNAs and
moRNAs are presented as 5p reads, i.e. derived from the 5′ arm of the pri-miRNA stem-
loop, or as 3p reads. An asterisk indicates a strain-speciﬁc RRVmiRNA sequence isoform
that differs from the isoform previously reported (Schäfer et al., 2007).
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2005). As yet, only a small number of mRNA targets for the KSHV
miRNAs have been identiﬁed. However, it appears thatmiRNA-induced
down-regulation of both cellular and viral genes contributes to the
creation of a cellular environment favorable for KSHV latency and/or
replication (Umbach and Cullen, 2009).
Rhesus monkey rhadinovirus (RRV), a rhadinovirus that naturally
infects rhesus macaques, is a close relative of KSHV that can induce a
similar pattern of pathogenic effects, including abnormal B cell
proliferation and cancer, in its simian host (Desrosiers et al., 1997;
Orzechowska et al., 2008;Wong et al., 1999). RRV has been previously
reported to encode seven pre-miRNAs, which were originally
identiﬁed by conventional sequencing of cDNAs generated from
small RNAs expressed in latently RRV-infected monkey vascular
endothelial cells (MVECs) (Schäfer et al., 2007). Although transcripts
targeted by RRV miRNAs have yet to be identiﬁed, RRV is genetically
tractable, easily grown in cell culture and has a well-deﬁned animal
model, making it a potentially ideal system to study the contribution
of virally encoded miRNAs to primate rhadinovirus pathogenesis both
in vitro and in vivo (Bilello et al., 2006; DeWire et al., 2003; Estep et al.,
2007).
However, an accurate functional analysis of RRVmiRNAs cannot be
accomplished without knowledge of the full complement of RRV
miRNAs. Although many protein-coding genes encoded by KSHV and
RRV show obvious homology, there appears to be little conservation
of miRNAs at the sequence level (Schäfer et al., 2007), making it
difﬁcult to determine if all RRV miRNAs have been identiﬁed. To
comprehensively identify all miRNAs encoded by RRV, cDNA libraries
generated from small RNAs expressed in two distinct RRV-induced
tumors, a retroperitoneal ﬁbromatosis (RF) and a B-cell lymphoma,
were subjected to deep sequencing. In addition to recovering all
previously reported RRV miRNAs (Schäfer et al., 2007), deep
sequencing also identiﬁed 8 novel viral pre-miRNAs. It was also
determined that the RRV miRNA previously identiﬁed as miR-rR1-3 is
actually a moRNA that has silencing activity similar to conventional
miRNAs. These data not only identify the full complement of miRNAs
encoded by RRV but also shed light on the origin and function of the as
yet poorly characterized moRNAs.
Results
Deep sequencing of small RNAs from RRV-infected tumor samples
Tissue froma latently RRV-infectedRF (18483) andB-cell lymphoma
(19286) were obtained postmortem from RRV-infected rhesus maca-
ques. Small RNAs 18 to 24nts in lengthwere isolated fromboth samples
and used to prepare cDNA libraries for Solexa/Illumina sequencing
(Umbach and Cullen, 2010). Deep sequencing returned 4,512,216
usable reads from the RF sample and 2,440,978 reads from the B-cell
lymphoma sample. Of these, 571,791 and 303,871 sequences, respec-
tively, were identiﬁed as cellularmiRNAs by comparison to themiRBase
13.0 database. As themiRNA transcriptomeof rhesusmacaques remains
incompletely deﬁned, this likely represents an underestimate. Of the
remaining reads derived from the RF and B-cell lymphoma samples,
242,095 and 127,407, respectively, mapped to the RRV genome
(AF083501). The vast majority of these viral sequences (N99%) were
identiﬁed as RRV miRNAs and in both tumors this represented ~30% of
the total miRNA reads obtained. A comprehensive list of the major
mature RRVmiRNA isoforms recoveredduring this analysis is presented
in Supplementary Tables 1 and 2.
In addition to recovering all the previously reported RRV miRNAs,
miR-rR1-1 through miR-rR-7 (Schäfer et al., 2007), 8 novel pre-
miRNAs, designated here as miR-rR1-8 through miR-rR1-15, were
also identiﬁed in both the RF and B-cell lymphoma sample (Table 1).
Secondary structure predictions demonstrated that the loci encom-
passing all novel RRV miRNA candidates could be readily folded intothe hairpin structures typical of canonical pri-miRNAs (Fig. 1) (Bartel,
2004). Additionally, both the 5p and 3p arms of the miRNA duplex
intermediate were recovered for six of the eight novel RRV pre-
miRNAs and these displayed the predicted ~2-nt 3′ overhangs (Bartel,
2004), thus further conﬁrming that these are indeed genuine miRNAs.
All novel RRV miRNAs identiﬁed mapped to the viral latency-
associated region (Fig. 2). Moreover, these novel RRV miRNAs were
found interspersed among, and in the same transcriptional orienta-
tion as, the previously identiﬁed RRV miRNAs. This suggests that
expression of the entire RRV miRNA locus is coordinated and that all
RRV miRNAs likely derive from a single pri-miRNA precursor, as
previously observed for the KSHV miRNAs (Cai and Cullen, 2006).
Identiﬁcation of RRV moRNAs in vivo
The in-depth sequence coverage afforded by deep sequencing
permitted the recovery of several previously unidentiﬁed small RRV
RNAs, including the pre-miRNA terminal loop of miR-rR1-2 and
several RRV moRNAs (Table 1 and data not shown). Importantly, it is
apparent that the small RNA previously annotated as miR-rR1-3 is
actually amoRNA derived from the pri-miR-rR1-3 precursor, now that
the 5p and 3p arms of themiRNA duplex intermediate have both been
recovered at high levels (Table 1 and Fig. 4A). These sequences will be
designated miR-rR1-3-5p and miR-rR1-3-3p, while the previously
designated “miR-rR1-3” and its corresponding star strand will be
referred to as moR-rR1-3-5p andmoR-rR1-3-3p, respectively. Of note,
the previous effort to identify RRV miRNAs failed to recover either
miR-rR1-3-5p or -3p and recovered the moR-rR1-3-5p sequence only
once (Schäfer et al., 2007).
Expression levels of novel RRV miRNAs in vivo and in latently infected
MVECs
Expression of the novel RRV miRNAs identiﬁed in Table 1 was
further conﬁrmed by stem-loop qRT–PCR using custom primers
designed to assay the most abundant isoform of each miRNA
recovered from deep sequencing (Supplementary Tables 1 and 2).
Assay of the original RF and B-cell lymphoma samples used for deep
sequencing conﬁrmed the expression of miR-rR1-3, miR-rR1-8, miR-
Fig. 1. Predicted secondary structures of the novel primary miRNA hairpins. Predicted pri-miRNA stem-loops formed by the novel RRV miRNAs identiﬁed during deep sequencing of
small RNAs derived from RRV-infected tumor samples. Red sequences indicate the dominant form of thematuremiRNA, while blue sequences indicate the less-abundant star strand,
if recovered. It should be noted that the pri-miRNA stem is generally ~11 bp longer than the mature pre-miRNA hairpin (Zeng et al., 2005).
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samples (Fig. 3A). Of all the miRNAs assayed, miR-rR1-14 was con-
sistently expressed at the lowest level, while the remaining miRNAs
were expressed at fairly comparable levels.
To determine if the previous lack of recovery of the novel RRV
miRNAs listed in Table 1 was due to their low expression in the RRV
infected MVECs originally used as a source of infected cell RNA
(Schäfer et al., 2007), we also used qRT–PCR to analyze latently RRV-
infected MVECs harvested at 23 or 44 days post-infection (dpi). This
yielded results similar to those seen with the tumor samples, with
miR-rR1-14 again being the least expressedmiRNA and the remainingFig. 2. Genomic location of the RRV pre-miRNAs. These are shown relative to viral protein co
arrows indicate previously identiﬁed RRV miRNAs, while gray arrows indicate novel RRV mi
as indicated.miRNAs detected at fairly comparable levels (Fig. 3B). Interestingly,
the level of RRV miRNAs did not appear to change between 23 and
44 dpi, suggesting that viral miRNAs may reach a steady-state level
during latent MVEC infection.
Technical difﬁculties (such as biased G:C or A:U content, or the
potential for the sequence to homodimerize) precluded the design of
RT–PCR primers for, and thus the veriﬁcation of, miR-rR1-10 andmiR-
rR1-12 expression. However, given the predicted secondary struc-
tures of the loci surrounding both miRNAs (Fig. 1) and the recovery of
the miR-rR1-12 star strand from deep sequencing (Table 1), we
believe that these are also authentic RRV miRNAs.ding genes (black arrows) located adjacent to the RRV latency-associated region. White
RNAs identiﬁed in this study. Transcriptional orientations of viral genes and miRNAs are
Fig. 3. RRV miRNA expression levels determined by qRT–PCR. All values are given as fold
expression relative to an uninfected control sample andare normalized to levels of a cellular
miRNA,miR-16. (A) Expression levels of RRVmiRNAs in the RF tumor sample (18483; gray)
and the B-cell lymphoma (19286; white). RNA recovered from RRV-uninfected tissue
derived from the same animals served as the negative controls. (B) Expression levels of RRV
miRNAs in latently infected MVECs harvested 23 (gray) or 44 dpi (white). RNA from
uninfected MVECs served as the negative control.
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MoRNAs were ﬁrst identiﬁed in lower eukaryotes (Shi et al., 2009)
and, more recently, viral moRNAs have also been identiﬁed in cells
infected by KSHV, HSV-1, and HSV-2 (Jurak et al., 2010; Umbach and
Cullen, 2010). The deﬁning characteristic of moRNAs is that they
derive from sequences located either immediately 5′ or 3′ to a pre-
miRNA, and it is therefore apparent that one end of a moRNAmust be
generated by Drosha cleavage of the pri-miRNA. However, it has
remained unclear whether moRNAs are loaded into RISC and even
how moRNAs are processed. It is possible that the other end of the
moRNA is generated either by a second cleavage by Drosha, in the
nucleus, or by Dicer cleavage, in the cytoplasm. It has also been
suggested that moRNAs might simply be breakdown products
generated at low levels during miRNA processing (Babiarz et al.,
2008), analogous, for instance, to the pre-miRNA loop sequences that
are sometimes recovered (Umbach and Cullen, 2010).
To determine if moR-rR1-3-5p has the ability to down-regulate
complementary transcripts in a manner similar to traditional miRNAs,
and is therefore loaded into RISC, an expression construct containing
the pri-miR-rR1-3 region (Fig. 4B) was cotransfected into 293T cells
along with luciferase based indicator constructs bearing an artiﬁcial,
perfect target site for either miR-rR1-3-3p or moR-rR1-3-5p. When
compared to expression of a luciferase indicator bearing an unrelated
target site, miR-rR1-3-3p speciﬁcally downregulated expression of its
cognate indicator by ~10-fold (Fig. 4C). In contrast, moR-rR1-3-5p
induced a more moderate but still signiﬁcant ~3-fold down-regulation
of its indicator. These data therefore strongly suggest that moR-rR1-3-
5p is able to program RISC.
Examination of the miR-rR-3 locus revealed that miR-rR1-3-5p is
encoded only 51 nt 3′ of the 3p arm of the pre-miR-rR-12 hairpin
(Fig. 4B). This is perhaps surprising given previous reports demon-
strating that Drosha prefers to cleave pri-miRNA stem-loops ﬂanked
by unstructured RNA sequence (Zeng and Cullen, 2005). (It should be
noted that the pri-miRNA stem-loop is ~11 bp longer than the pre-
miRNA stem, as shown in Fig. 1). Although we were not able to assaymiR-rR1-12 levels by RT–PCR for technical reasons, both strands of the
predicted miR-rR1-12 miRNA duplex intermediate were recovered by
deep sequencing, as were both strands of the miR-rR1-3-3p duplex
intermediate (Table 1). Moreover, miR-rR1-3-3p expression was also
readily detected by RT–PCR (Fig. 3). Therefore, despite their close
physical proximity, miR-rR1-12 and miR-rR1-3 are clearly both
expressed in latently RRV-infected cells.
In an attempt to directly examine miR-rR1-3-3p and moR-rR1-3-
5p expression levels, RNA was harvested from 293T cells transfected
with the same full-length miR-rR1-3 expression construct (Fig. 4).
Hybridization with a miR-rR1-3-3p-speciﬁc probe resulted in detec-
tion of the mature miRNA at the expected size of ~20 nt (Fig. 5). The
larger band of between 40 and 50 nts is presumably the pre-miR-rR1-3
precursor, although this migrated somewhat faster than the expected
~56-nt size (Fig. 4B).
When the same samples were hybridized with a moR-rR1-3-5p-
speciﬁc probe, no RNA with the expected ~18-nt size of moR-rR1-3-
5p was detected. This was not unexpected, given the low frequency of
recovery of this moRNA by deep sequencing (Table 1). However, a
larger band of between 40 and 50 nts was detected by themoR-rR1-3-
5p-speciﬁc probe. This is presumably a moRNA processing interme-
diate that includes the moRNA sequence as well as 5′ ﬂanking
sequences up to the 3′ end of miR-rR1-12-3p (Fig. 4B). However,
similar to the pre-miR-rR1-3 band, this band also appeared slightly
smaller than the expected 51-nt size. To conﬁrm the identity of this
band, we generated a second moR-rR1-3 expression plasmid by
deleting sequences located 5′ to the loop of the adjacent pri-miR-rR1-
12 stem-loop (Fig. 4), which should block miR-rR1-12 processing
without affecting miR-rR1-3 expression. The 51-nt moR-rR1-3-5p-
speciﬁc band resulting from Drosha cleavage of both the miR-rR1-12
and miR-rR1-3 pri-miRNA stem-loops should therefore be lost and
replaced by a predicted 157-nt band extending from the 5′miR-rR1-3
Drosha cleavage site to the transcription start site. Indeed, the “ΔmiR-
rR1-R3” expression vectorwas found to generate the predicted ~160-nt
miR-rRi-3-5p speciﬁc band, but no ~45-nt speciﬁc band, in transfected
293T cells (Fig. 5), yet did not affect the pattern of miR-rR1-3 speciﬁc
bands.
Discussion
In this article, we report the use of deep sequencing technology to
detect the expression of 15 distinct RRV pre-miRNA species in a
latently RRV-infected B-cell lymphoma and RF tumor harvested from
two rhesus macaques infected with the 17577 strain of RRV.
Previously, conventional sequencing was used to identify seven RRV
pre-miRNAs expressed in MVECs latently infected with RRV strain 26-
95 (Schäfer et al., 2007), and all of these were also detected in vivo.
Interestingly, one RRV miRNA, miR-rR1-4-3p, does differ by a single
nucleotide between these two RRV strains (Fig. 6A), but as this single
nucleotide difference lies outside the miRNA seed sequence, it may
have little or no effect on the pattern of mRNAs regulated by this viral
miRNA.
RRV is a close relative of KSHV and both viruses cause a similar
pattern of disease in immunodeﬁcient hosts. However, a comparison
of the sequences of the 15 RRV miRNAs described in this article and
earlier (Schäfer et al., 2007) with the known KSHV miRNAs (Cai et al.,
2005; Grundhoff et al., 2006; Pfeffer et al., 2005; Samols et al., 2005)
identiﬁes only one example of signiﬁcant sequence homology.
Speciﬁcally, the newly described miR-rR1-15 miRNA bears an
identical seed sequence to the previously described KSHV miRNA
miR-K10a (Fig. 6B). However, as the mRNA species targeted by miR-
K10a remain to be deﬁned, the signiﬁcance of this conservation is
currently unclear. Nevertheless, the observed homology does imply
that these two viral miRNAs are likely performing similar functions in
RRV- and KSHV-infected cells that, uniquely, have been conserved
during primate rhadinovirus miRNA evolution.
Fig. 4. Activity of miR-rR1-3-3p andmoR-rR1-3-5p. (A) Predicted secondary structure of the pri-miR-rR1-3 hairpin. The sequence of mature miR-rR1-3-3p is indicated in red and the
miR-rR1-3-5p star strand shown in blue. The dominant arm of moR-rR1-3 is indicated in teal and the corresponding star strand in green. (B) Schematic of the full-length and 5′
truncated miR-rR1-3 expression constructs expanded to show relative sizes and locations of mature miRNAs, moRNAs, and cleavage intermediates. MiRNAs and moRNAs indicated
in bold designate the dominant arms recovered from deep sequencing. The arrow indicates the 5′ border of the 5′ truncated ΔmiR-rR1-3 expression construct. Hatched yellow boxes
represent basal stem sequences of pri-miR-rR1-12. (C) Inhibitory activity of miR-rR1-3-3p (red) and moR-rR1-3-5p (teal) revealed in transfected 293T cells using luciferase-based
indicator plasmids bearing two perfectly complementary target sites. Values are displayed relative to a control indicator bearing an unrelated sequence (gray), which was set at
100%. Average of three independent experiments with standard deviation indicated.
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proportion of this miRNA is edited by an adenosine deaminase,
resulting in the modiﬁcation of the adenosine located at position 2 of
miR-K10a to inosine (Fig. 6B). This modiﬁcation changes the miR-Fig. 5. Detection of RRV small RNAs. Northern blots for miR-rR1-3-3p (left panel) and
moR-rR1-3-5p (right panel) using RNA samples derived from 293T cells transfected
with the indicated expression plasmids. Expression constructs used and expected
fragment sizes are diagramed in Fig. 4B. Endogenous U6 RNA served as a loading
control.K10a seed and generates an alternative miRNA isoform called miR-
K10b (Pfeffer et al., 2005). However, we did not detect a signiﬁcant
level of editing of miR-rR1-15 or, indeed, of any RRV-encoded miRNA
(data not shown).
Although the miRNAs encoded by RRV and KSHV are therefore
largely distinct, all 12 viral pri-miRNAs encoded by KSHV and all 15
pri-miRNAs encoded by RRV are found in the same genomic location
in both viruses, within the latency-associated region and 3′ to the
shared ORF71 gene (Fig. 2) (Cai et al., 2005; Pfeffer et al., 2005; Samols
et al., 2005). This implies that RRV and KSHV evolved from a common
ancestor that ﬁrst acquired one or more miRNA stem-loops in the
latency region of the genome and then underwent evolutionary
divergence, leading to the current pattern of virus-speciﬁc miRNA
sequences.
As noted in previous deep sequencing surveys and RT–PCR
veriﬁcation studies (Git et al., 2010; Umbach and Cullen, 2010), we
observed only a modest correlation betweenmiRNA expression levelsFig. 6. Sequence conservation of RRV miRNAs. (A) This alignment contrasts the
sequences of the RRV miRNA miR-rR1-4-3p in the RRV strains 17577, used in this
report, and 26-95, used in a previous publication (Schäfer et al., 2007). (B) Sequence
alignment of miR-rR1-15 with the KSHVmiRNAmiR-K10a. In both cases, the conserved
miRNA seed regions are indicated, as are conserved bases.
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rR1-14 was the least frequently recoveredmiRNA by deep sequencing
(Table 1), which correlates well with the qRT–PCR data, where it was
also the least expressed RRV miRNA of those assayed (Fig. 3). In
contrast, miR-rR1-8 and miR-rR1-11, which were both recovered at
low to intermediate levels by deep sequencing, were both detected at
relatively high levels by qRT–PCR. In fact, levels of miR-rR1-8 and
miR-rR1-11 detected by qRT–PCR were comparable to the levels of
miR-rR1-13 and miR-rR1-15, although these latter two miRNAs were
recovered at 10 to 100 greater frequencies by deep sequencing. These
discrepancies likely reﬂect biases inherent in both the deep
sequencing and qRT–PCR methodologies. Notably, deep sequencing
results can be inﬂuenced by linker ligation and PCR ampliﬁcation
biases, whereas stem-loop qRT–PCR is inﬂuenced by PCR primer
annealing efﬁciency as well as by the inability of each primer set to
efﬁciently detect more than a single miRNA 3′ sequence isoform,
which may underestimate total miRNA expression levels.
Despite these caveats, it is worth comparing the level of recovery
of the previously reported RRV miRNAs (Schäfer et al., 2007) with the
levels of the novel viral miRNAs identiﬁed in this study to determine if
the novel miRNAs were not previously recovered simply because they
are expressed at low levels in latently infected MVECs. While deep
sequencing frequencies of individual RRV miRNAs varied greatly, this
does not appear to be the case; two novel miRNAs, miR-rR1-13 and
miR-rR1-15, were the two most abundant miRNAs recovered from
deep sequencing in both the RF and B-cell lymphoma samples and in
the latently infected MVECs. This may imply that the different RRV
strains used in this study (RRV17577) or the earlier study (RRV26-95)
(Schäfer et al., 2007) express individual miRNAs at different levels.
However, sequence analysis indicates that all the newly reported RRV
miRNAs are in fact present and intact in the RRV26-95 strain.
Overall, the RRV miRNA proﬁles derived from the RF and B-cell
lymphoma samples are remarkably similar; deep sequencing recov-
ered a similar pattern of mature miRNAs and star strands from both
samples. Speciﬁcally, the more abundant arm of each pre-miRNA
hairpin was identical in both tumor samples except for miR-rR1-11,
where numbers for both the 5p and 3p arms were similar in both
samples. Together, these data suggest that the in vivo RRV miRNA
expression proﬁles are relatively consistent regardless of tumor type
and that we have likely identiﬁed a comprehensive list of viral pre-
miRNAs expressed during latent RRV infection.
As discussed above, the small RNA previously annotated as miR-
rR1-3 is more accurately designated moR-rR1-3-5p. Unfortunately,
assay of moR-rR1-3-5p expression levels by RT-PCR was not possible
due to the inability of the stem-loop primers to distinguish themature
moRNA from the highly abundant 5′ ﬂanking region generated by
Drosha cleavage of pri-miR-rR1-3 (Fig. 5). On the other hand, wewere
able to demonstrate that moR-rR1-3-5p has at least moderate
inhibitory activity using a luciferase-based indicator assay (Fig. 4),
thus strongly suggesting that this moRNA is loaded into RISC and can
target complementary transcripts for inhibition in a manner identical
to miRNAs. This argues that moRNA biogenesis occurs in the
cytoplasm and likely requires cleavage by Dicer.
We speculate that sufﬁcient base-pairing at the base of the pri-
miRNA stem (Fig. 4A) can transiently hold the sequences ﬂanking the
pri-miRNA together after pre-miRNA excision by Drosha, thus
allowing the 2-nt 3′ overhang on the dsRNA “pre-moR” precursor to
be bound, and possibly stabilized, by Exportin5 leading to nuclear
export. We hypothesize that this moRNA precursor can also remain at
least transiently base-paired in the cytoplasm, thus allowing Dicer to
bind the 3′ overhang resulting fromDrosha cleavage. Dicer cleavage of
the stem could then generate a “moRNA duplex intermediate,” which
would then be available for RISC loading and subsequent transcript
targeting. The existence of such moRNA duplex intermediates, closely
analogous in structure to miRNA duplex intermediates, is strongly
suggested by the recovery of both moR-5p and moR-3p RNAs fromseveral viral pri-miRNAs, including miR-rR1-3 in this article, miR-K4
and miR-K10 in KSHV (Umbach and Cullen, 2010) and miR-H4 and
miR-H6 in HSV-1 (Jurak et al., 2010).
In support of this hypothesis, we note that viral moRNAs tend to
arise from pri-miRNA stem-loops that are closely ﬂanked, 5′ and/or 3′,
by other pri-miRNAs stem-loops. Coordinated Drosha cleavage of this
cluster of three pri-miRNAs would generate short RNAs ﬂanking the
central stem that may transiently maintain the short stem derived
from the base of the pri-miRNA stem-loop (Figs. 1 and 4A). Of note,
the most abundant species of RRV moRNA recovered by deep
sequencing was derived from sequences adjacent to pre-miR-rR1-6.
The pri-miR-rR1-6 hairpin is closely ﬂanked upstream by pri-miR-
rR1-15 and downstream by pri-miR-rR1-7. Drosha cleavage of pri-
miR-rR1-6 and these two ﬂanking pri-miRNAs are predicted to
generate 5′ and 3′ ﬂanking fragments 59 and 87 nts in length,
respectively. These sequences may be short enough so that the pri-
miRNA basal stem is sufﬁcient to keep the two fragments base-paired
for export by Exportin 5 and cleavage by Dicer to generate the ﬁnal
moRNA, moR-rR1-6-5p (Table 1). Similarly, the moR-rR1-3 analyzed
in Figs. 4 and 5, the second most abundant moRNA recovered from
deep sequencing, is also closely ﬂanked 5′ by pre-miR-rR1-12 (Fig. 4)
and 3′ by pre-miR-rR1-4. Although Drosha cleavage is predicted to
result in a 3′ ﬂanking fragment of 373 nt, the 5′ ﬂanking fragment is
expected to be only 51 nts long (Figs. 4B and 5). Again, the short
length of the 5′ ﬂanking sequence may allow this RNA fragment to
remain base-paired to the 3′ ﬂanking sequence (Fig. 4A) during
nuclear export and subsequent Dicer cleavage. Similarly, moR-K4-5p,
detected in KSHV-infected cells, is predicted to derive from the 73 nt
sequence that separates miR-K4 from miR-K3.
If the close proximity of pri-miRNA stems indeed facilitates moRNA
biogenesis, then this would explain why moRNAs have been reported
more frequently in viruses, with their tightly packed genomes, than in
cells. Nevertheless, moRNA biogenesis is clearly still very inefﬁcient in
comparison tomiRNA biogenesis, as evidenced by the far lowermoRNA
frequencies recovered by deep sequencing (Table 1) and the lower
inhibitory activity observed (Fig. 4C). Whether moRNAs are expressed
at levels sufﬁcient to exert a signiﬁcant phenotypic effect in any setting,
including herpesvirus-infected cells, currently remains unclear.
Materials and methods
Animal tissues
RF tumor and B-cell lymphoma tissues were derived from
RRV17577-infected animals 18483 and 19286, respectively, and have
been characterized and described (Orzechowska et al., 2008).
Approximately 100 mg of frozen tumor tissue or control tissue
(muscle) from each animal was placed into 500 μl of Tri-reagent
(Applied Biosystems, Foster City, CA) and homogenized with a tissue
tearor for RNA extraction according to manufacturer's directions.
Solexa/Illumina sequencing and data analysis
cDNA libraries for deep sequencing were prepared as outlined
previously (Umbach and Cullen, 2010). Thirty micrograms of total
RNA from RRV-infected tumor samples was used to isolate small RNAs
(18–24 nt) that were then copied into cDNA using linkers described in
the Solexa Digital Gene Expression Kit but chemically modiﬁed as
described in Lau et al. (2001). Importantly, the 3′ linker (IDT,
Coralville, IA) was 5′ adenylated and 3′ blocked to minimize ligation
artifacts. Raw sequence data were returned in FASTA format and 3′
linker sequences were removed. The sequence list was then indexed,
collapsed, and size ﬁltered for sequences 18 to 24 nts in length to
generate a ﬁnal list for MegaBLAST analysis. Sequences were analyzed
against the RRV genome (AF083501) and the mature human miRNA
dataset from miRBase (release 13.0) using the formatdb, megablast,
598 J.L. Umbach et al. / Virology 405 (2010) 592–599blastoutparse, and ﬁlter alignment scripts from the miRDeep software
package (Friedlander et al., 2008).
Quantitation of miRNA expression by qRT–PCR
RRV miRNA expression levels were analyzed using the TaqMan
MicroRNA Assay System (Applied Biosystems, Foster City, CA)
according to the manufacturer's directions. Brieﬂy, 10 ng of total
RNA was used as a template for reverse transcription. The sample was
diluted to 60 μl, of which 8 μl was used for stem-loop qRT-PCR.
Custom primers for detecting the most abundant isoform of each viral
miRNA were designed by Applied Biosystems (Foster City, CA). Each
reverse transcription reaction was performed twice independently,
and each reaction was used for triplicate PCR. All values were
normalized to the ubiquitously expressed cellular miRNA, miR-16,
and all viral miRNA levels are displayed as fold expression relative to
RNA derived from uninfected tissue samples harvested from the same
animal or from uninfected MVECs, which were calculated as outlined
by Livak and Schmittgen (2001).
Cell culture and RNA
293T cells were maintained in Dulbecco's modiﬁed Eagle medium
(Sigma-Aldrich, St. Louis, MO) supplemented with 10% fetal bovine
serum. Primary rhesus MVEC cultures (MVEC21150 CGB-5, kindly
provided by Dr. Jay Nelson) were maintained in endothelial cell
medium 2 (EBM-2; Cambrex BioScience, Walkersville, MD) supple-
mented with Single Quots (Cambrex). MVEC cultures were infected
with approximately 2×105 infectious units of RRV17577-GFP (S. Wong,
unpublished results), passed when conﬂuent and maintained for the
indicated length of time. Total RNA was isolated using Tri-reagent
(Applied Biosystems, Foster City, CA) according to the manufacturer's
directions.
Expression vectors, indicator plasmids, and luciferase assays
Renilla luciferase indicators for miR-rR1-3-3p and moR-rR1-3-5p
were cloned by annealing synthetic oligonucleotides perfectly
complementary to either miR-rR1-3-3p or moR-rR1-3-5p into the
XbaI and ClaI sites downstream of the Renilla gene in the pNL-SIN-
CMV-RLuc vector, as previously described (Gottwein et al., 2006). The
full-length miR-rR1-3 expression construct was generated using
primers centered around the pre-miR-rR1- 3 hairpin to PCR a 262-
bp fragment from 293T cells infected with a RRV-GFP virus (Schäfer
et al., 2007), which was then cloned into the BamHI and EcoRI sites of
pcDNA3 (Invitrogen, Carlsbad, CA). The ΔmiR-rR1-3 expression
construct is similar to the full-length construct, except that the 5′
end is truncated to the miR-rR1-12 terminal loop. 293T cells were
transfected with 25 ng of the indicator plasmid together with 1 μg of
each expression construct. Samples were harvested in lysis buffer
24 hours post-transfection, and luciferase expression was assayed
using the Renilla Luciferase Assay System (Promega, Madison, WI).
Expression levels are displayed relative to values obtained with a
control indicator construct bearing an irrelevant target site. Final
values and standard deviations represent the average of three
independent experiments. Transfections were performed in duplicate
so that the parallel sample could be harvested for Northern blot
analysis.
Northern blots
MiRNA Northern blots were carried out as previous described (Cai
et al., 2004). Brieﬂy, 30 μg of total RNAwas separated on 15% TBE-urea
gels (Bio-Rad, Hercules, CA) and then transferred onto nitrocellulose
membranes. Following UV cross-linking, membranes were probed
with radioactively end-labeled DNA oligonucleotides complementaryto each target miRNA or moRNA. Blots were then probed for endog-
enous U6 RNA, which served as a loading control.
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